null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Anti-Synaptotagmin-7 Antibody [N275/14 (Formerly sold as S275-14)]

SKU STMA00131
Antibody Type Monoclonal
Applications WB
Applications IHC
Applications ICC/IF
Reactivity Human
Reactivity Mouse
Reactivity Rat
Host Species Mouse
Isotype IgG2B
€647
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Synaptotagmin-7 Antibody [N275/14 (Formerly sold as S275-14)]

Synaptotagmin-7 Antibody [N275/14 (Formerly sold as S275-14)] is a mouse monoclonal antibody directed against Synaptotagmin-7, offered by Assay Genie for research applications. Reported applications include WB, IHC and ICC/IF. Reported reactivity: Human, Mouse and Rat. Supplied as IgG2B, purified by Protein G.

Synaptotagmin 7 (SYT7) is a member of the synaptotagmin family, a group of membrane-trafficking proteins characterized by an N-terminal transmembrane domain and two C-terminal C2 domains (C2A and C2B) that mediate calcium-dependent interactions. Among the 15 known mammalian synaptotagmins, SYT7 plays a distinct role in regulating synaptic vesicle exocytosis, asynchronous neurotransmitter release, and synaptic plasticity. Unlike its counterparts that mediate fast, synchronous release, SYT7 is essential for sustained neurotransmission and vesicle replenishment during prolonged neuronal activity. It binds acidic phospholipids in a calcium-dependent manner and interacts with key synaptic proteins such as Stonin 2, neurexins, syntaxin, and AP2, influencing vesicle docking and fusion dynamics. Recent studies implicate SYT7 in neurodegenerative disease mechanisms, including Alzheimer’s disease and Parkinson’s disease, where synaptic dysfunction and impaired vesicle trafficking are early pathological features. Altered SYT7 expression or function may disrupt calcium signaling, neurotransmitter release, and synaptic maintenance, contributing to cognitive decline and neuronal vulnerability. Given its central role in calcium sensing and synaptic regulation, SYT7 is emerging as a promising target for therapeutic intervention in neurodegenerative disorders. Understanding SYT7’s molecular interactions and regulatory mechanisms is critical for advancing strategies aimed at preserving synaptic integrity and neuronal communication in aging and disease. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose